Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Rugge

Showing results (431-440 of 459) with videos related to

Pageof 46
Sort By:
The Lancet. Oncology|May 23, 2008
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre studyArmando Bartolazzi, Fabio Orlandi, Enrico Saggiorato, et al.
Endoscopy|August 29, 2015
Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) GuidelinePedro Pimentel-Nunes, Mário Dinis-Ribeiro, Thierry Ponchon, et al.
The Oncologist|January 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesFotios Loupakis, Ilaria Depetris, Paola Biason, et al.
International Journal of Cancer|January 6, 2021
Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in ItalyLauro Bucchi, Silvia Mancini, Emanuele Crocetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2019
Class 1, 2, and 3 <i>BRAF</i>-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular CharacterizationMarta Schirripa, Paola Biason, Sara Lonardi, et al.
Virchows Archiv : an International Journal of Pathology|May 8, 2021
Prognostic relevance and putative histogenetic role of cytokeratin 7 and MUC5AC expression in Crohn's disease-associated small bowel carcinomaGiovanni Arpa, Alessandro Vanoli, Federica Grillo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 10, 2015
Assessment of a HER2 scoring system for colorectal cancer: results from a validation studyEmanuele Valtorta, Cosimo Martino, Andrea Sartore-Bianchi, et al.
Cancer Discovery|July 12, 2020
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated MacrophagesIlaria Marigo, Rosalinda Trovato, Francesca Hofer, et al.
Cancer Medicine|June 18, 2019
Prognosis and cure of long-term cancer survivors: A population-based estimationLuigino Dal Maso, Chiara Panato, Stefano Guzzinati, et al.
British Journal of Cancer|September 3, 2019
CK7 and consensus molecular subtypes as major prognosticators in <sup>V600E</sup>BRAF mutated metastatic colorectal cancerFotios Loupakis, Paola Biason, Alessandra Anna Prete, et al.
Pageof 46

Showing results (431-440 of 459) with videos related to

Sort By:
Pageof 46
The Lancet. Oncology|May 23, 2008
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre studyArmando Bartolazzi, Fabio Orlandi, Enrico Saggiorato, et al.
Endoscopy|August 29, 2015
Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) GuidelinePedro Pimentel-Nunes, Mário Dinis-Ribeiro, Thierry Ponchon, et al.
The Oncologist|January 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesFotios Loupakis, Ilaria Depetris, Paola Biason, et al.
International Journal of Cancer|January 6, 2021
Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in ItalyLauro Bucchi, Silvia Mancini, Emanuele Crocetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2019
Class 1, 2, and 3 <i>BRAF</i>-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular CharacterizationMarta Schirripa, Paola Biason, Sara Lonardi, et al.
Virchows Archiv : an International Journal of Pathology|May 8, 2021
Prognostic relevance and putative histogenetic role of cytokeratin 7 and MUC5AC expression in Crohn's disease-associated small bowel carcinomaGiovanni Arpa, Alessandro Vanoli, Federica Grillo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 10, 2015
Assessment of a HER2 scoring system for colorectal cancer: results from a validation studyEmanuele Valtorta, Cosimo Martino, Andrea Sartore-Bianchi, et al.
Cancer Discovery|July 12, 2020
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated MacrophagesIlaria Marigo, Rosalinda Trovato, Francesca Hofer, et al.
Cancer Medicine|June 18, 2019
Prognosis and cure of long-term cancer survivors: A population-based estimationLuigino Dal Maso, Chiara Panato, Stefano Guzzinati, et al.
British Journal of Cancer|September 3, 2019
CK7 and consensus molecular subtypes as major prognosticators in <sup>V600E</sup>BRAF mutated metastatic colorectal cancerFotios Loupakis, Paola Biason, Alessandra Anna Prete, et al.
Pageof 46